Dr. Cohen on Eligibility for Ablation Therapy in Liver Cancer

Video

In Partnership With:

Emil Israel Cohen, MD, an assistant professor at Medstar Georgetown University Hospital, discusses the criteria for ablation therapy in patients with liver cancer.

Emil Israel Cohen, MD, an assistant professor at Medstar Georgetown University Hospital, discusses the criteria for ablation therapy in patients with liver cancer.

According to Cohen, eligibility criteria boil down to the size and location of the tumor. An ablated tumor ≤3 cm is associated with a 90% cure rate. Tumors up to 5 cm can be ablated, but the approach is less likely to result in cure.

Cohen says that with advances in liver cancer treatment, ablation is not always the optimal intervention. In the past five years, treatment protocols have moved away from aggressive management strategies to combination approaches with chemoembolization and ablation, as well as the use of radioembolization and external beam radiation.

Ultimately, treatment should be personalized based on the patient’s individual needs, Cohen concludes.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD